Know Cancer

or
forgot password


Phase 2
18 Years
65 Years
Open (Enrolling)
Both
Uveal Malignant Melanoma

Thank you

Trial Information


Inclusion Criteria:

Uveal malignant melanoma, liver only metastases, ECOG 0-1 -

Exclusion Criteria:Extra hepatic disease, previous other maligency, previous organ
transplantation

-

Type of Study:

Interventional

Study Design:

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Over all survival

Authority:

Norway:Regional Ethics Committee

Study ID:

S-06408

NCT ID:

NCT01311466

Start Date:

January 2011

Completion Date:

January 2018

Related Keywords:

  • Uveal Malignant Melanoma
  • Liver transplantation
  • Overall survival
  • Melanoma

Name

Location